Roche regains reputation crown among rare disease patient groups, with Amgen close behind apark Tue, 08/20/2024 – 10:56 More: Roche regains reputation crown among rare disease patient groups, with Amgen close behind Source: fierce
read moreAfter Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly fkansteiner Tue, 08/20/2024 – 10:28 More: After Europe deal, Organon pays .5M to expand Emgality marketing pact with Lilly Source: fierce
read more
Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause More: Theramex’s Eladynos recommended by NICE for post-menopausal bone disease Source: News
read more
The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services More: eXmoor pharma’s manufacturing facility receives licence from MHRA Source: News
read moreWere industry watchers too optimistic after IRA’s price cut reveal? Analysts weigh in fkansteiner Mon, 08/19/2024 – 14:18 More: Were industry watchers too optimistic after IRA's price cut reveal? Analysts weigh in Source: fierce
read moreFDA balks at standard approval of Liquidia’s PAH rival to United’s Tyvaso after lengthy court saga zbecker Mon, 08/19/2024 – 11:13 More: FDA balks at standard approval of Liquidia's PAH rival to United's Tyvaso after lengthy court saga Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals